Announcements Trials

Browse Landscape

Phase

Status

Recruiting 16 Completed 16 Active not recruiting 7 Withdrawn 6 Terminated 6 Unknown 3 Suspended 1 Not yet recruiting 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Leukemia, Myeloid, Acute 7 Carcinoma, Renal Cell 3 Triple Negative Breast Neoplasms 2 Myelodysplastic Syndromes 2 Multiple Myeloma 2 Lymphoma, T-Cell 2 Lymphoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Colorectal Neoplasms 2 Clear-cell metastatic renal cell carcinoma 2 Breast Neoplasms 2 Waldenstrom Macroglobulinemia 1 Thrombocytosis 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Synovial 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Rhabdomyosarcoma 1 Prostatic Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Neurofibrosarcoma 1 Neuroblastoma 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Mouth Neoplasms 1 Lymphoma, Mantle-Cell 1 Lymphoma, B-Cell, Marginal Zone 1

Interventions

Androgen Antagonists 10 darolutamide 6 Magnetic Resonance Spectroscopy 6 apalutamide 5 Docetaxel 5 enzalutamide 4 Specimen Handling 4 Radiotherapy 4 Radiosurgery 4 Abiraterone Acetate 4 Electroacupuncture 3 Brachytherapy 3 pembrolizumab 2 bicalutamide 2 Standard of Care 2 Resistance Training 2 Radiation 2 Prednisone 2 Pluvicto 2 Interviews as Topic 2 Gonadotropin-Releasing Hormone 2 Glutamate Carboxypeptidase II 2 Bone Density 2 Absorptiometry, Photon 2 testosterone 17 beta-cypionate 1 relugolix 1 perflutren 1 olaparib 1 luprolide acetate gel depot 1 fluciclovine F-18 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Prostatic Neoplasms × Biopsy × Clear all

NCT07526545 2026-04-13

UPRISE

University of Michigan Rogel Cancer Center

Phase NA Not yet recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡